The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cytori Therapeutics Inc

Nasdaq: CYTX
Last

(U.S.) $1.55

Today's change-0.05 -3.13%
Updated January 20 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Cytori Therapeutics Inc

Nasdaq: CYTX
Last

(U.S.) $1.55

Today's change-0.05 -3.13%
Updated January 20 4:00 PM -5GMT. Delayed by at least 15 minutes.

Cytori Therapeutics Inc crosses below 50-day moving average

Cytori Therapeutics Inc closed sharply lower Friday, dropping (U.S.)$0.05 or 3.13% to (U.S.)$1.55 and crossing below its 50-day moving average. Over the last five days, shares have lost 1.90% and 31.11% over the last 52 weeks. This security has underperformed the S&P 500 by 53.27% during the last year.

Key company metrics

  • Open(U.S.) $1.58
  • Previous close(U.S.) $1.60
  • High(U.S.) $1.60
  • Low(U.S.) $1.51
  • Bid / Ask(U.S.) $1.50 / (U.S.) $1.75
  • YTD % change+2.65%
  • Volume108,345
  • Average volume (10-day)165,019
  • Average volume (1-month)316,919
  • Average volume (3-month)171,424
  • 52-week range(U.S.) $1.36 to (U.S.) $5.44
  • Beta2.68
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.32
Updated January 20 4:00 PM -5GMT. Delayed by at least 15 minutes.
S&P TSX0.90%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue3333
Total other revenue--------
Total revenue3333
Gross profit2223
Total cost of revenue1111
Total operating expense7985
Selling / general / administrative3333
Research & development4545
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-5-6-5-2
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets0000
Other--------
Income before tax-5-6-5-3
Income after tax-5-6-5-3
Income tax, total--------
Net income-5-6-5-3
Total adjustments to net income0000
Net income before extra. items-5-6-5-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-6-5-3
Inc. avail. to common incl. extra. items-5-6-5-3
Diluted net income-5-6-5-3
Dilution adjustment--------
Diluted weighted average shares20151411
Diluted EPS excluding extraordinary itemsvalue per share-0.26-0.43-0.37-0.25
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.26-0.43-0.37-0.25